KR860001793A - 벤즈 이미다졸 유도체의 제조방법 - Google Patents

벤즈 이미다졸 유도체의 제조방법 Download PDF

Info

Publication number
KR860001793A
KR860001793A KR1019850006307A KR850006307A KR860001793A KR 860001793 A KR860001793 A KR 860001793A KR 1019850006307 A KR1019850006307 A KR 1019850006307A KR 850006307 A KR850006307 A KR 850006307A KR 860001793 A KR860001793 A KR 860001793A
Authority
KR
South Korea
Prior art keywords
structural formula
following structural
compound
benzimidazole derivatives
carbon atoms
Prior art date
Application number
KR1019850006307A
Other languages
English (en)
Other versions
KR920004936B1 (ko
Inventor
스스무 오카베 (외 4)
Original Assignee
우시야마 게이죠오
닛봉 케미화 가부시키 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP59182400A external-priority patent/JPS6160660A/ja
Priority claimed from JP60061194A external-priority patent/JPH068283B2/ja
Priority claimed from JP60061195A external-priority patent/JPH0764826B2/ja
Application filed by 우시야마 게이죠오, 닛봉 케미화 가부시키 가이샤 filed Critical 우시야마 게이죠오
Publication of KR860001793A publication Critical patent/KR860001793A/ko
Application granted granted Critical
Publication of KR920004936B1 publication Critical patent/KR920004936B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms

Abstract

내용 없음

Description

벤즈 이미다졸 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 하기 구조식(Ⅱ)의 2-르르캅토벤즈이미다졸을 하기 구조식(Ⅲ)의 2-아미노벱질 화합물과 반응시켜 하기 구조식(Ⅳ)의 화합물을 형성하고, 이 하기 구조식(Ⅳ)의 화합물을 산화시키는 것으로 구성되는 하기 구조식(Ⅰ)의 벤즈이미다졸 유도체의 제조방법.
    상기식에서, R1은 수소원자 혹은 탄소수 1-8인 알킬기 혹은 시클로알킬, 페닐, 아랄킬기이고, R2는 수소원자 혹은 탄소수 1-8인 알킬기이거나, R1과 R2는 근접한 질소원자와 함께 고리를 형성하고, R3와 R4는 각각 수소 혹은 할로겐원자 혹은 트리플루오로메틸, 저급알킬, 저급알콕시, 저급알콕시카르보닐 혹은 아미노기이고, X는 반응기이다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019850006307A 1984-08-31 1985-08-30 벤즈이미다졸 유도체의 제조방법. KR920004936B1 (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP182400 1984-08-31
JP59182400A JPS6160660A (ja) 1984-08-31 1984-08-31 ベンズイミダゾ−ル誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
JP60061194A JPH068283B2 (ja) 1985-03-26 1985-03-26 ベンズイミダゾ−ル誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
JP61194 1985-03-26
JP60061195A JPH0764826B2 (ja) 1985-03-26 1985-03-26 ベンズイミダゾール誘導体
JP61195 1985-03-26

Publications (2)

Publication Number Publication Date
KR860001793A true KR860001793A (ko) 1986-03-22
KR920004936B1 KR920004936B1 (ko) 1992-06-22

Family

ID=27297422

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850006307A KR920004936B1 (ko) 1984-08-31 1985-08-30 벤즈이미다졸 유도체의 제조방법.

Country Status (14)

Country Link
KR (1) KR920004936B1 (ko)
AR (1) AR242195A1 (ko)
AU (3) AU4640985A (ko)
BE (1) BE903128A (ko)
BR (1) BR8504252A (ko)
CH (1) CH665417A5 (ko)
DE (1) DE3531487C2 (ko)
ES (1) ES8703142A1 (ko)
FR (1) FR2569691B1 (ko)
GB (1) GB2163747B (ko)
IT (1) IT1189601B (ko)
MX (1) MX159807A (ko)
NL (1) NL8502384A (ko)
SE (1) SE500669C2 (ko)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8417194D0 (en) * 1984-07-05 1984-08-08 Boots Co Plc Therapeutic agents
EP0174717B1 (en) 1984-07-06 1992-01-22 FISONS plc Benzimidazoles, and their production formulation and use as gastric acid secretion inhibitors
GB2161160B (en) * 1984-07-06 1989-05-24 Fisons Plc Heterocyclic sulphinyl compounds
AU5768886A (en) * 1985-05-24 1986-11-27 G.D. Searle & Co. 2-((1-h-benzimidazol-2-ylsulfinyl)methyl)benzenamines
US5869513A (en) * 1985-05-24 1999-02-09 G. D. Searle & Co. 2- (1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines
US4824856A (en) * 1985-08-14 1989-04-25 Nippon Chemiphar Co., Ltd. Method of protecting gastrointestinal tract
WO1987001114A2 (en) * 1985-08-21 1987-02-26 Byk Gulden Lomberg Chemische Fabrik Gmbh New amines, process for their manufacture, their use and medicines containing them
AR243167A1 (es) 1985-08-24 1993-07-30 Hoechst Ag Procedimiento para la preparacion de toluidinas sustituidas.
AU619444B2 (en) * 1986-06-02 1992-01-30 Nippon Chemiphar Co. Ltd. 2-(2-aminobenzylsulfinyl)- benzimidazole derivatives
EP0251536A1 (en) * 1986-06-24 1988-01-07 FISONS plc Benzimidazoles, their production, formulation and use as gastric acid secretion inhibitors
US4687775A (en) * 1986-07-17 1987-08-18 G. D. Searle & Co. 2-[(Imidazo[1,2-a]pyridinylmethyl)sulfinyl]-1H-benzimidazoles
US4772619A (en) * 1986-07-17 1988-09-20 G. D. Searle & Co. [(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines
US4721718A (en) * 1986-08-18 1988-01-26 G. D. Searle & Co. 2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles useful in the treatment and prevention of ulcers
DE3639926A1 (de) * 1986-11-22 1988-06-01 Hoechst Ag Substituierte thienoimidazoltoluidin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer
IT1222412B (it) * 1987-07-31 1990-09-05 Chiesi Farma Spa Tiometil e sulfinil metil derivati ad azione antisecretiva acida gastrica,loro procedimento di preparazione e composizioni farmaceutiche che li contengono
JP2614756B2 (ja) * 1988-08-10 1997-05-28 日本ケミファ株式会社 イミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
JPH06298611A (ja) * 1993-04-16 1994-10-25 Nippon Chemiphar Co Ltd 抗菌剤
SE9301489D0 (sv) 1993-04-30 1993-04-30 Ab Astra Veterinary composition
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
HRP960232A2 (en) * 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds
DE69631834T2 (de) * 1995-09-21 2005-02-10 Pharma Pass Ii Llc, Irvine Neues ein säureempfindliches benzimidazol enthaltendes mittel und verfahren zu dessen herstellung
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
US6380222B2 (en) 1996-10-11 2002-04-30 Astrazeneca Ab Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps
ES2232015T3 (es) 1997-07-25 2005-05-16 Altana Pharma Ag Inhibidor de las bombas de protones en combinacion terapeutica con sustancias antibacterianas.
SE9704870D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
CA2507743C (en) 1998-08-12 2008-03-18 Altana Pharma Ag Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles
WO2000027841A1 (en) * 1998-11-06 2000-05-18 Dong-A Pharmaceutical Co., Ltd. Method of preparing sulfide derivatives
TWI243672B (en) 1999-06-01 2005-11-21 Astrazeneca Ab New use of compounds as antibacterial agents
KR100833633B1 (ko) 1999-06-07 2008-05-30 니코메드 게엠베하 산에 불안정한 활성 화합물을 포함하는 신규 제제 및 투여형태
SE9903831D0 (sv) * 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
SE0000774D0 (sv) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
US6544556B1 (en) 2000-09-11 2003-04-08 Andrx Corporation Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
PT1492511E (pt) 2002-04-09 2009-04-09 Flamel Tech Sa Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s)
WO2003084517A2 (fr) 2002-04-09 2003-10-16 Flamel Technologies Suspension orale de microcapsules d’amoxicilline
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
NZ546148A (en) 2003-09-26 2009-05-31 Alza Corp Drug coating providing high drug loading and methods for providing the same
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US9561188B2 (en) 2006-04-03 2017-02-07 Intellipharmaceutics Corporation Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
ES2511792T3 (es) 2006-07-25 2014-10-23 Vecta Ltd. Composiciones y métodos para la inhibición de la secreción de ácido gástrico usando derivados de pequeños ácidos dicarboxílicos en combinación con IBP
CA2673665C (en) 2006-12-22 2017-03-21 Ironwood Pharmaceuticals, Inc. Method and compositions for treating esophageal disorders
EP2344139A1 (en) 2008-09-09 2011-07-20 AstraZeneca AB Method for delivering a pharmaceutical composition to patient in need thereof
EP2445499A4 (en) 2009-06-25 2013-02-27 Astrazeneca Ab METHOD FOR TREATING A PATIENT WITH RISK OF DEVELOPING A NSAID-ASSOCIATED SPURGE
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080500A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
US20120294937A1 (en) 2009-12-29 2012-11-22 Novartis Ag New pharmaceutical dosage form for the treatment of gastric acid-related disorders
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
EP2601947A1 (en) 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases
BR112014016085A8 (pt) 2011-12-28 2017-07-04 Pozen Inc composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico
EA201591338A1 (ru) 2013-01-15 2016-01-29 Айронвуд Фармасьютикалз, Инк. Гастроретентивная лекарственная форма секвестранта желчных кислот с замедленным высвобождением для перорального применения
EP2801565B1 (en) * 2013-05-06 2015-07-22 King Saud University Compounds for use as anti-ulcer agent and/or anti-Helicobacter pylori agent and pharmaceutical compositions thereof
WO2016126625A1 (en) 2015-02-03 2016-08-11 Ironwood Pharmaceuticals, Inc. Methods of treating upper gastrointestinal disorders in ppi refractory gerd

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
EP0174717B1 (en) * 1984-07-06 1992-01-22 FISONS plc Benzimidazoles, and their production formulation and use as gastric acid secretion inhibitors

Also Published As

Publication number Publication date
AU2975092A (en) 1993-01-28
IT1189601B (it) 1988-02-04
ES8703142A1 (es) 1986-11-16
DE3531487A1 (de) 1986-03-13
AR242195A1 (es) 1993-03-31
AU4127189A (en) 1989-12-21
DE3531487C2 (de) 1995-08-17
FR2569691A1 (fr) 1986-03-07
AU647978B2 (en) 1994-03-31
KR920004936B1 (ko) 1992-06-22
AU4640985A (en) 1986-03-06
GB2163747A (en) 1986-03-05
SE8504048L (sv) 1986-03-01
IT8567743A0 (it) 1985-08-30
SE500669C2 (sv) 1994-08-08
BR8504252A (pt) 1986-06-17
GB8521493D0 (en) 1985-10-02
BE903128A (fr) 1985-12-16
FR2569691B1 (fr) 1989-08-04
CH665417A5 (fr) 1988-05-13
GB2163747B (en) 1989-02-08
ES546445A0 (es) 1986-11-16
SE8504048D0 (sv) 1985-08-30
NL8502384A (nl) 1986-03-17
MX159807A (es) 1989-08-31

Similar Documents

Publication Publication Date Title
KR860001793A (ko) 벤즈 이미다졸 유도체의 제조방법
KR850007254A (ko) 니트로메틸렌 유도체의 제조방법
KR850006404A (ko) 니트로 메틸렌 유도체의 제조방법
KR840004406A (ko) 히단토인의 제조방법
KR830007686A (ko) 세팔로 스포린 유도체의 제조방법
KR850004754A (ko) 3-인돌 카르복사미드 화합물류의 제조방법
ES8700253A1 (es) Procedimiento para preparar compuestos de 5-alquil-1-fenil- -2-piperazinoalquilpirazolin-3-ona
KR830005110A (ko) 플루오렌 유도체의 제조방법
KR860001097A (ko) 4-아미노-2-페닐퀴놀린의 제조방법
KR860002450A (ko) 아미노-알콜유도체의 제조방법
KR830004210A (ko) 2-아미노-3-벤조일-페닐아세트아미드 및 환상 동족체
KR850002979A (ko) 1,2,3-트리티안화합물의 신규 제조방법
KR840002821A (ko) N-(2,3-에폭시프로필렌)-n-아르알킬술폰아미드 유도체의 제조방법
KR830005225A (ko) 데오필린의 피페라진 유도체의 제조방법
KR830002716A (ko) 구아니딘 화합물의 제조방법
KR860002474A (ko) 치환된 페닐술포닐아졸의 제조방법
KR860002486A (ko) 티아진포스폰산 유도체의 제조방법
KR850007247A (ko) 바이페닐릴설포닐 우레아의 제조방법
KR840004105A (ko) N,n- 치환된 아졸 카복스 아미드 유도체의 제조방법
KR860007215A (ko) 벤조아미드 유도체의 제조방법
KR870008838A (ko) 아릴술폰 화합물 제조방법
KR840003633A (ko) 피리미돈 화합물의 제조방법
KR920007971A (ko) 벤조퀴논 화합물
KR860004063A (ko) 알킬리덴 디옥시 화합물의 제조방법
KR850004583A (ko) 페닐아세트아닐리드 유도체의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19990206

Year of fee payment: 8

LAPS Lapse due to unpaid annual fee